Lorna is currently Vice President, Commercial Operations of Seqirus.
Lorna has enjoyed a successful 25-year career in the pharmaceutical industry, encompassing clinical research, business development, marketing and sales, all across a wide variety of therapeutic areas including: Respiratory, CNS, Cardiopulmonary, Metabolic, Psychiatry, Neurology, HIV and Vaccines. She has worked in the U.S., Europe and Asia Pacific. In 2002 Lorna immigrated to Australia and worked for GSK Australia as the Commercial Vice President for five years. In 2009, she established Ikaria Australia Pty Ltd, a biotherapeutics company that commercialises drugs and devices for intensive care medicine.
Lorna graduated with a PhD in Neurobiology (University College London); BSc in Pharmacology (University of Glasgow) and went on to hold academic positions at the Cardiothoracic Institute at the Royal Brompton Hospital (London) and at the Royal Post Graduate Medical School (London).